Development of Mesoporous Silica Nanoparticles and Studying The Effect of Surface Modification on EGFP Plasmid Transfection in Cancer Cell Line.

Publish Year: 1393
نوع سند: مقاله کنفرانسی
زبان: English
View: 615

متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

ICNN05_035

تاریخ نمایه سازی: 30 آبان 1394

Abstract:

Nano-mediated delivery systems have became as more applicable methods in medical field than other nonviralsystems due to having enhanced transfection and controlled released of genetic materials and drugs to target cellsand organs. Chemically modified MSNs have attracted more interests in recent years since their specific properties suchas chemically and thermally stability with adjustable morphology and porosity. In this study MCM-41 and modifiedstructures with amine and imidazole groups are improved for gene delivery and experimental gene therapy. The modifiedstructure were characterized via FT-IR spectroscopy and the amount of chemical elements was determined by CHNanalysis. The Crystallinity was detected by XRD technique. Morphological characteristic were determined by TEM andFE-SEM which showed nanoparticle formation in the size ranges between 60-100 nm. Synthesized carriers were loadedwith EGFP plasmid and their complexes were examined with agarose gel retardation assay and DNase1 digestion. Thesurface charge of MSN-DNA were defined by zeta potential. Gene transfection of this modified nano-carriers wereexamined at different N/P by monitoring expression of GFP with flowcytometry and their cytotoxicity was tested byMTT method. The results have shown the efficiency of modified MCM-41 structures while having amine and imidazolegroups in gene delivery.

Authors

M Mahmoodi

Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran- Student Research Committee, Shiraz University of Medical Science, Shiraz, Iran

F Farjadian

Center for Nanotechnology in Drug Delivery, Shiraz University of MedicalScience,Shiraz,Iran

N Golkar

Center for Nanotechnology in Drug Delivery, Shiraz University of MedicalScience,Shiraz,Iran

A Behzad-Behbahani

Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran